Skip to main content

Table 2 SBRT treatment characteristics

From: Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch® patient registry

 

Primary NSCLC

Lung Metastases

p-value

Number of Lesions

48

66

 

Prescribed Dose (Gy)

  

0.0001

 Median

48

37.5

 

 Range

(20 – 60)

(16 – 60)

 

BED10 (Gy)

  

0.0005

 Median

105.6

93.6

 

 Range

48 – 180

37.5 – 180

 

Dmax (Gy)

   

 Median

72.7

66.2

0.048

 Range

(40.5 – 105)

(21.7 – 94)

 

Number of fractions

  

0.013

 Median

4

3

 

 Range

1–5

1–5

 
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us